09:37 JIWA BIO-PHARM<02327> - Announcement (1) The Stock Exchange of Hong Kong Limited takes no responsibility for the contents of this announcement, makes no representation as to its accuracy or completeness and expressly disclaims any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement. Jiwa Bio-Pharm Holdings Limited (Incorporated in Bermuda with limited liability) (Stock Code : 2327) DISCLOSEABLE TRANSACTION JOINT VENTURE IN MANUFACTURING PHARMACEUTICAL BULK MATERIALS SUMMARY Reference is made to the announcement of the Company dated 11 November 2004, in which it was announced that Jiwa Rintech would construct a new plant in the PRC for the manufacture of pharmaceutical bulk materials. Pursuant to Rule 14.36 of the Listing Rules, the Directors announce that they have decided on 20 May 2005 to change the plan. After considering a number of options, the Directors considered that it is in the interest of the Company to invest in a PRC JV Company instead of constructing its own plant. On 25 May 2005, Jiwa Rintech entered into the Capital Injection Agreement with Party A, Party B and Party C, pursuant to which Jiwa Rintech agreed to make a capital contribution of RMB24,000,000 (equivalent to approximately HK$22.6 million) and Party A agreed to make an additional capital contribution of RMB172,300 (equivalent to approximately HK$0.16 million) in the PRC JV Company. The investment of Jiwa Rintech in the PRC JV Company constitutes a discloseable transaction for the Company under the Listing Rules. A circular containing, amongst others, details of the Capital Injection Agreement and the injection of capital into the PRC JV Company will be sent to the shareholders of the Company as soon as practicable. THE CAPITAL INJECTION AGREEMENT Date : 25 May 2005 Parties : (a) Jiwa Rintech (b) Party A (c) Party B (d) Party C To the best of the Directors' knowledge, information and belief after all reasonable enquiry, each of Party A, Party B, Party C and their respective ultimate beneficial owners is third party independent of the Group and connected persons (as defined in the Listing Rules) of the Group. Content : Jiwa Rintech agreed to make a capital contribution of RMB24,000,000 (equivalent to approximately HK$22.6 million) in the PRC JV Company and Party A agreed to make an additional capital contribution of RMB172,300 (equivalent to approximately HK$0.16 million) in the PRC JV Company. The amount of contribution by Jiwa Rintech was determined with reference to the costs of setting up a new manufacturing plant in the PRC as contemplated by the Group. Party A agreed to contribute RMB172,300 so at to round up the registered capital of the PRC JV Company from RMB29,827,700 to RMB30,000,000. The PRC JV Company was established in November 2003. As